MarketPeel
Insider Trading Intelligence
GA

Gonzalez David Angulo

SCYX
CHIEF MEDICAL OFFICER · SCYNEXIS INC · CIK 0001644071
FILING MIX · LIFETIME91%/9%
BUYS
20
SELLS
2
TOTAL VALUE
$142.2K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
1,357,126
AVG SELL PX
$7.45
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by Gonzalez David Angulo, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%+16.31%+2.41%+13.90%+13.55%
14d4+100.00%+19.61%+4.14%+15.46%+16.83%
30d4+100.00%+14.27%+7.08%+7.20%+5.85%
60d4+25.00%-0.68%+6.72%+12.52%+12.52%
90d4+25.00%-15.70%+10.56%-26.26%-39.91%
180d4(2 pending)+50.00%-5.84%+6.80%-12.64%-12.64%
1y4(2 pending)+50.00%+2.24%+23.13%-20.89%-20.89%
2y4(3 pending)+0.00%-71.91%+8.13%-80.04%-80.04%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SCYX · 1,357,126 shares · as of Apr 1, 2026
0339,282678,5631,017,8451,357,126202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 2 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SCYX
SCYNEXIS INC
PURCHASE
Chief Executive Officer
108,695108,695Apr 1, 2026Apr 2, 2026View →
SCYX
SCYNEXIS INC
PURCHASE
Chief Executive Officer
108,6951,357,126Apr 1, 2026Apr 2, 2026View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
391,3331,244,431Jan 29, 2026Feb 2, 2026View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
32,500$0.76$24.7K853,098Oct 17, 2025Oct 21, 2025View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
23,000$0.84$19.3K816,598Apr 9, 2025Apr 10, 2025View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
13,800$1.05$14.5K793,598Mar 20, 2025Mar 20, 2025View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
5,000$1.07$5.3K779,798Mar 19, 2025Mar 20, 2025View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
394,391394,391Jan 23, 2025Jan 27, 2025View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
262,927770,798Jan 23, 2025Jan 27, 2025View →
SCYX
SCYNEXIS INC
PURCHASE
Chief Executive Officer
20,000$1.37$27.4K507,871Sep 12, 2024Sep 16, 2024View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
290,590479,871Jan 26, 2024Jan 30, 2024View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
431,030431,030Jan 26, 2024Jan 30, 2024View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
110,000185,181Jan 1, 2023Jan 3, 2023View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
165,000165,000Jan 1, 2023Jan 3, 2023View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
51,10074,981Feb 4, 2022Feb 8, 2022View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
85,00085,000Feb 4, 2022Feb 8, 2022View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
65,00065,000Jan 29, 2021Feb 2, 2021View →
SCYX
SCYNEXIS INC
PURCHASE
Chief Medical Officer
1,600$6.25$10.0K23,780Dec 21, 2020Dec 23, 2020View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
800800Dec 21, 2020Dec 23, 2020View →
SCYX
SCYNEXIS INC
SALE
Chief Medical Officer
4,323$6.81$29.4K22,180Nov 25, 2020Dec 4, 2020View →
SCYX
SCYNEXIS INC
SALE
Chief Medical Officer
1,175$9.80$11.5K26,303Feb 15, 2020Dec 4, 2020View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
450,000450,000Jan 31, 2020Feb 4, 2020View →
Other insiders · SCYX
Loading peer insiders…
About this filer
CIK 0001644071
ROLE
Chief Medical Officer
PRIMARY
SCYX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001644071DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback